Key Advances in Oncology, 2018
Our team reviews the most important advances in oncology in 2018, including those in breast cancer, hematologic cancers, lung cancer, immunotherapy, and more.
Oncology Conference Highlights, Q4
Our team reviews 2018 conference highlights in oncology care, including studies from ASH, SABCS, and SIO.
Management of Neutropenic Toxicity From CDK4/6 Inhibitors
An oncology pharmacist discusses how to manage neutropenic toxicity from treatment with CDK4/6 inhibitors for HR-positive breast cancer.
Pathologic Hip Fracture in a 49-Year-Old Man With Widespread Metastatic Sclerotic Bone Lesions
In this case, we examine a 49-year-old man with widespread metastatic sclerotic bone lesions. What is your diagnosis?
